rhodioloside has been researched along with amyloid beta-peptides in 2 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (amyloid beta-peptides) | Trials (amyloid beta-peptides) | Recent Studies (post-2010) (amyloid beta-peptides) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 3,257 | 48 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, XQ; Kong, WN; Li, X; Shao, TM; Song, LG; Zhang, J; Zhen, YF | 1 |
| Chen, C; Chen, J; Huang, X; Xing, S; Yu, Z | 1 |
2 other study(ies) available for rhodioloside and amyloid beta-peptides
| Article | Year |
|---|---|
Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.
Topics: Acetylcholine; Acetylcholinesterase; Amyloid beta-Peptides; Animals; Cognition Disorders; Cyclooxygenase 2; Glucosides; Hippocampus; Inflammation Mediators; Male; Maze Learning; Microinjections; NADPH Oxidases; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Peptide Fragments; Phenols; Rats; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2013 |
Salidroside protects PC12 cells from Aβ1‑40‑induced cytotoxicity by regulating the nicotinamide phosphoribosyltransferase signaling pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Glucosides; Neuroprotective Agents; Nicotinamide Phosphoribosyltransferase; PC12 Cells; Peptide Fragments; Phenols; Rats; Rhodiola; Signal Transduction | 2017 |